|
|
|
|
| LEADER |
01000caa a22002652 4500 |
| 001 |
NLM375917004 |
| 003 |
DE-627 |
| 005 |
20240927232612.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
240806s2024 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1002/adma.202409528
|2 doi
|
| 028 |
5 |
2 |
|a pubmed24n1550.xml
|
| 035 |
|
|
|a (DE-627)NLM375917004
|
| 035 |
|
|
|a (NLM)39104292
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Zou, Faxing
|e verfasserin
|4 aut
|
| 245 |
1 |
2 |
|a A Fully Integrated Conformal Wearable Ultrasound Patch for Continuous Sonodynamic Therapy
|
| 264 |
|
1 |
|c 2024
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 27.09.2024
|
| 500 |
|
|
|a Date Revised 27.09.2024
|
| 500 |
|
|
|a published: Print-Electronic
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a © 2024 Wiley‐VCH GmbH.
|
| 520 |
|
|
|a Cancer treatment is a continuous process, that the current therapy cannot meet the requirement well, including radiotherapy and chemotherapy. Wearable ultrasound device has the potential for continuous sonodynamic therapy due to its portability. However, the miniaturization of ultrasonic probe, system integration of device, and the strategy of continuous treatment are still urgent issues to be addressed. Herein, a portable wearable antitumor system is introduced, which utilizes a custom-developed multiplexed ultrasonic patch array (CWUS Patch) to accurately focus ultrasound on the lesion site and controllably stimulate sonosensitizer to produce a large amount of toxic reactive oxygen species (ROS). The system enables dynamic control of the ultrasound patches and allows real-time adjustments to optimize their performance in various applications, providing greater flexibility and precision in healthcare technology. Furthermore, the excellent penetration property of ultrasound into tumor tissues that induce synchronous apoptosis of tumor cells from the inside out is verified through a mouse model of breast cancer. This fully integrated conformal wearable ultrasound system provides a promising approach to noninvasively, continuously, and efficiently treat deep tumors
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a antitumor
|
| 650 |
|
4 |
|a sonodynamic therapy
|
| 650 |
|
4 |
|a ultrasound patch
|
| 650 |
|
4 |
|a wearable
|
| 650 |
|
7 |
|a Reactive Oxygen Species
|2 NLM
|
| 700 |
1 |
|
|a Luo, Yong
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Zhuang, Wenxuan
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Xu, Tailin
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Advanced materials (Deerfield Beach, Fla.)
|d 1998
|g 36(2024), 39 vom: 06. Sept., Seite e2409528
|w (DE-627)NLM098206397
|x 1521-4095
|7 nnns
|
| 773 |
1 |
8 |
|g volume:36
|g year:2024
|g number:39
|g day:06
|g month:09
|g pages:e2409528
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1002/adma.202409528
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 36
|j 2024
|e 39
|b 06
|c 09
|h e2409528
|